Prospective Clinical Trial of Three Apical Sealing Materials
NCT ID: NCT04198298
Last Updated: 2019-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
59 participants
INTERVENTIONAL
2014-11-02
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regenerative Endodontics for Non-vital Primary Molars
NCT05098483
Clinical Assessment of 3 Differant Obturation Sealers on Postoprative Pain and Swelling
NCT05419752
Regenerative Endodontic Treatment of Mature Necrotic Teeth With Apical Periodontitis
NCT04018456
Treatment Outcome of Ortho MTA (BioMTA®) Cement vs AH Plus® Bioceramic Sealer (Dentsply).
NCT05984940
Periapical Healing in Response to Endodontically Treated Teeth With Different Sealing Cement
NCT06482593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 EndoSequence
The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.
EndoSequence
The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.
Group 2 ProRoot MTA
The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.
ProRoot MTA
The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.
Group 3 Biodentine
The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.
Biodentine
The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EndoSequence
The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.
ProRoot MTA
The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.
Biodentine
The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any tooth with a single chronic periapical lesion requiring apical microsurgery
* Informed consent signed prior to surgery
Exclusion Criteria
* Adjacent periapical lesion
* Periodontal disease
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Pacific
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-60
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.